ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Rumors Preceded Broder’s Move

December 22, 1994

Surgical Oncologists Honor HHS Secretary

March 22, 2002

PRI Fires Gilden, Compten, Sues For $1 Million By May Be Out Of Recompetition; NCI Is “Neutral”

August 8, 1986

NCCS Networker Volume 4 Issue 2, Spring 1990

April 13, 1990

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007